​In February 2024, the 7th Antibody China's  was successfully concluded at Shanghai. The HypercellⓇ platform and related products brought by Bioelectronica Holdings, Inc. had remarkable results in this event. Its advantages of high throughput screening, precise identification, automated operation and wide applicability attracted a lot of attention from the industry, and also showed the future potential of Bioelectronica in the field of antibody drug discovery and development!

​

This exhibition not only strengthened the communication and cooperation between Bioelectronica Holdings, Inc. and the industry, but also injected new vitality into the whole field of antibody drug and ADC drug development. We look forward to continuing to contribute more to the development of the industry in the future!

​